Oncolytics Biotech, Inc. (ONCY)
0.95
-0.03
(-2.95%)
USD |
NASDAQ |
Mar 20, 16:00
0.9614
+0.01
(+1.20%)
After-Hours: 20:00
Oncolytics Biotech Research and Development Expense (Quarterly) : 5.457M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 10.90M |
| Edesa Biotech, Inc. | 1.125M |
| Lexaria Bioscience Corp. | 0.6713M |
| Xenon Pharmaceuticals, Inc. | 87.09M |
| ProMIS Neurosciences, Inc. | 9.797M |